Enhancement Training for the Next Generation of Translational Ph.D. Scientists
Enhancement Training for the Next Generation of Translational Ph.D. Scientists
批准号:
10413926
负责人:
Alisa S. Wolberg
金额:
$19.26万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
In this revision of T32-GM122741, the UNC Program in Translational Medicine requests five years of support
to train basic science Ph.D. students to perform translational research on topics of clinical significance, working
in multidisciplinary teams composed of scientists, physician-scientists, and clinicians, using state-of-the-art
experimental approaches and patient-derived resources to address clinically-relevant needs. The UNC
Program in Translational Medicine was born out of the Med-into-Grad Initiative of the Howard Hughes Medical
Institute and has now existed for >10 years. Over this period of time, the UNC Program in Translational
Medicine has trained 121 Ph.D. students from 15 different basic science programs in the UNC School of
Medicine, UNC School of Pharmacy, UNC School of Dentistry, UNC School of Public Health, and UNC College
of Arts and Sciences. The UNC Program in Translational Medicine provides enhancement training to
biomedical Ph.D. students leading to a Certificate in Translational Medicine which is conferred at the time of
completion of the Ph.D. Trainees in the UNC Program in Translational Medicine complete required coursework
related to the pathogenesis of human disease, participate in monthly programmatic activities, perform
translational research, and benefit from dual mentorship (with a basic science mentor and a clinical co-mentor).
The clinical co-mentors provide a tailored clinical experience for each trainee, exposing students to the
practical realities of the diseases they research and identifying questions of clinical significance that can be
addressed using basic science research methods and approaches. The required elements of the program
complement requirements of the individual Ph.D. programs, ensuring that the time-to-completion of the degree
is comparable to that of the typical Ph.D. student. Since its inception, 66 Ph.D. students have completed the
requirements for the Certificate in Translational Medicine. The long-term goal of the UNC Program in
Translational Medicine is to train a cadre of Ph.D. researchers with the knowledge and skills necessary to
recognize, appreciate, and address clinically-relevant biological problems from the perspective of basic
science. We anticipate that this next generation of translational Ph.D. scientists will understand which
biological problems are of greatest clinical relevance and will be positioned to apply new biological knowledge
to create tools for improved human health.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/cts.12803
发表时间:
2020-11
期刊:
Clinical and translational science
影响因子:
--
作者:
[Ge S, Mendley SR, Gerhart JG, Melloni C, Hornik CP, Sullivan JE, Atz A, Delmore P, Tremoulet A, Harper B, Payne E, Lin S, Erinjeri J, Cohen-Wolkowiez M, Gonzalez D, Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee]
通讯作者:
Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee
DOI:
10.1371/journal.pbio.3000956
发表时间:
2021-07
期刊:
PLoS biology
影响因子:
9.8
作者:
[Brandt PD, Sturzenegger Varvayanis S, Baas T, Bolgioni AF, Alder J, Petrie KA, Dominguez I, Brown AM, Stayart CA, Singh H, Van Wart A, Chow CS, Mathur A, Schreiber BM, Fruman DA, Bowden B, Wiesen CA, Golightly YM, Holmquist CE, Arneman D, Hall JD, Hyman LE, Gould KL, Chalkley R, Brennwald PJ, Layton RL]
通讯作者:
Layton RL
DOI:
10.1002/cpt.1990
发表时间:
2021-01
期刊:
Clinical pharmacology and therapeutics
影响因子:
6.7
作者:
[Salerno SN, Edginton A, Gerhart JG, Laughon MM, Ambalavanan N, Sokol GM, Hornik CD, Stewart D, Mills M, Martz K, Gonzalez D, Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee]
通讯作者:
Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee
DOI:
10.1007/s40262-021-01072-4
发表时间:
2022-03
期刊:
Clinical pharmacokinetics
影响因子:
4.5
作者:
[Gerhart JG, Carreño FO, Edginton AN, Sinha J, Perrin EM, Kumar KR, Rikhi A, Hornik CP, Harris V, Ganguly S, Cohen-Wolkowiez M, Gonzalez D, Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee]
通讯作者:
Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Enhancement Training for the Next Generation of Translational Ph.D. Scientists
-
批准号:10198943
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2018
-
负责人:Alisa S. Wolberg
-
依托单位:
Fibrinogen and Factor XIII in Venous Thrombosis
-
批准号:9205251
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2016
-
负责人:Alisa S. Wolberg
-
依托单位:
Fibrinogen and Factor XIII in Venous Thromboembolism
-
批准号:10205143
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2016
-
负责人:Alisa S. Wolberg
-
依托单位:
Fibrinogen and Factor XIII in Venous Thromboembolism
-
批准号:10649632
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2016
-
负责人:Alisa S. Wolberg
-
依托单位:
Fibrinogen and Factor XIII in Venous Thromboembolism
-
批准号:10463593
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2016
-
负责人:Alisa S. Wolberg
-
依托单位:
Fibrinogen and Factor XIII in Venous Thromboembolism
-
批准号:10065898
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2016
-
负责人:Alisa S. Wolberg
-
依托单位:
Determinants of Thrombus Structure and Stability
-
批准号:8903582
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2014
-
负责人:Alisa S. Wolberg
-
依托单位:
Cellular Determinants of Fibrin Structure and Stability
-
批准号:7930677
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2009
-
负责人:Alisa S. Wolberg
-
依托单位:
Cellular Determinants of Fibrin Structure and Stability
-
批准号:8073476
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2009
-
负责人:Alisa S. Wolberg
-
依托单位:
Cellular Determinants of Fibrin Structure and Stability
-
批准号:7735611
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2009
-
负责人:Alisa S. Wolberg
-
依托单位:
Cellular Determinants of Fibrin Structure and Stability
-
批准号:8456158
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2009
-
负责人:Alisa S. Wolberg
-
依托单位:
Cellular Determinants of Fibrin Structure and Stability
-
批准号:8277904
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2009
-
负责人:Alisa S. Wolberg
-
依托单位:
BIOCHEMICAL STUDIES OF BLOOD COAGULATION
-
批准号:7625665
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2006
-
负责人:Alisa S. Wolberg
-
依托单位:
Pathophysiology of anti-B2GPI Antibodies in APS
-
批准号:6759836
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2004
-
负责人:Alisa S. Wolberg
-
依托单位:
Pathophysiology of anti-B2GPI Antibodies in APS
-
批准号:7252124
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2004
-
负责人:Alisa S. Wolberg
-
依托单位:
Pathophysiology of anti-B2GPI Antibodies in APS
-
批准号:7103411
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2004
-
负责人:Alisa S. Wolberg
-
依托单位:
Pathophysiology of anti-B2GPI Antibodies in APS
-
批准号:7462459
-
项目类别:
-
资助金额:$10.29万
-
财政年份:2004
-
负责人:Alisa S. Wolberg
-
依托单位:
Pathophysiology of anti-B2GPI Antibodies in APS
-
批准号:6901026
-
项目类别:
-
资助金额:$9.63万
-
财政年份:2004
-
负责人:Alisa S. Wolberg
-
依托单位:
CELLULAR TISSUE FACTOR--REGULATION AND ACTIVITY
-
批准号:6183252
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2000
-
负责人:Alisa S. Wolberg
-
依托单位:
CELLULAR TISSUE FACTOR--REGULATION AND ACTIVITY
-
批准号:6030454
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1999
-
负责人:Alisa S. Wolberg
-
依托单位:
海外基金